Insider Transactions in Q2 2024 at Edwards Lifesciences Corp (EW)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 04
2024
|
Bernard J Zovighian CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,718
-7.35%
|
$316,030
$85.25 P/Share
|
|
May 04
2024
|
Bernard J Zovighian CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,265
+11.03%
|
-
|
|
May 04
2024
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Payment of exercise price or tax liability
|
Direct |
3,475
-7.7%
|
$295,375
$85.25 P/Share
|
|
May 04
2024
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
5,855
+11.48%
|
-
|
|
May 04
2024
|
Daveen Chopra CVP, TMTT |
SELL
Payment of exercise price or tax liability
|
Direct |
2,321
-8.54%
|
$197,285
$85.25 P/Share
|
|
May 04
2024
|
Daveen Chopra CVP, TMTT |
BUY
Exercise of conversion of derivative security
|
Direct |
4,713
+14.78%
|
-
|
|
May 04
2024
|
Larry L Wood Global President TAVR & Surg |
SELL
Payment of exercise price or tax liability
|
Direct |
3,541
-1.61%
|
$300,985
$85.25 P/Share
|
|
May 04
2024
|
Larry L Wood Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct |
6,675
+2.94%
|
-
|
|
May 04
2024
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
BUY
Exercise of conversion of derivative security
|
Direct |
4,157
+2.28%
|
-
|
|
May 04
2024
|
Daniel J. Lippis CVP, JAPAC |
SELL
Payment of exercise price or tax liability
|
Direct |
291
-1.69%
|
$24,735
$85.25 P/Share
|
|
May 04
2024
|
Robert W.A. Sellers SVP, Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
120
-0.79%
|
$10,200
$85.25 P/Share
|
|
May 04
2024
|
Catherine M. Szyman CVP, Critical Care |
SELL
Payment of exercise price or tax liability
|
Direct |
3,442
-7.02%
|
$292,570
$85.25 P/Share
|
|
May 04
2024
|
Catherine M. Szyman CVP, Critical Care |
BUY
Exercise of conversion of derivative security
|
Direct |
5,796
+10.57%
|
-
|
|
May 04
2024
|
Scott B. Ullem CVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,431
-17.1%
|
$376,635
$85.25 P/Share
|
|
May 04
2024
|
Scott B. Ullem CVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,465
+22.37%
|
-
|
|
May 03
2024
|
Bernard J Zovighian CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
527
-1.18%
|
$44,795
$85.06 P/Share
|
|
May 03
2024
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Payment of exercise price or tax liability
|
Direct |
479
-1.2%
|
$40,715
$85.06 P/Share
|
|
May 03
2024
|
Daveen Chopra CVP, TMTT |
SELL
Payment of exercise price or tax liability
|
Direct |
291
-1.28%
|
$24,735
$85.06 P/Share
|
|
May 03
2024
|
Larry L Wood Global President TAVR & Surg |
SELL
Payment of exercise price or tax liability
|
Direct |
395
-0.18%
|
$33,575
$85.06 P/Share
|
|
May 03
2024
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
SELL
Payment of exercise price or tax liability
|
Direct |
37
-0.02%
|
$3,145
$85.06 P/Share
|
|
May 03
2024
|
Daniel J. Lippis CVP, JAPAC |
SELL
Payment of exercise price or tax liability
|
Direct |
281
-1.61%
|
$23,885
$85.06 P/Share
|
|
May 03
2024
|
Robert W.A. Sellers SVP, Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
106
-0.69%
|
$9,010
$85.06 P/Share
|
|
May 03
2024
|
Catherine M. Szyman CVP, Critical Care |
SELL
Payment of exercise price or tax liability
|
Direct |
479
-1.1%
|
$40,715
$85.06 P/Share
|
|
May 03
2024
|
Scott B. Ullem CVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
634
-3.32%
|
$53,890
$85.06 P/Share
|
|
May 02
2024
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
29,350
-57.67%
|
$2,465,400
$84.8 P/Share
|
|
May 02
2024
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
29,350
+46.45%
|
$1,056,600
$36.75 P/Share
|
|
May 01
2024
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
SELL
Open market or private sale
|
Direct |
14,400
-3.86%
|
$1,209,600
$84.47 P/Share
|
|
May 01
2024
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
BUY
Exercise of conversion of derivative security
|
Direct |
14,400
+7.11%
|
$518,400
$36.75 P/Share
|
|
Apr 30
2024
|
Scott B. Ullem CVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,250
-14.11%
|
$623,500
$86.07 P/Share
|
|
Apr 30
2024
|
Scott B. Ullem CVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,250
+21.59%
|
$261,000
$36.75 P/Share
|
|
Apr 09
2024
|
Daniel J. Lippis CVP, JAPAC |
SELL
Open market or private sale
|
Direct |
857
-4.67%
|
$78,844
$92.34 P/Share
|
|
Apr 09
2024
|
Daniel J. Lippis CVP, JAPAC |
BUY
Exercise of conversion of derivative security
|
Direct |
857
+4.46%
|
$30,852
$36.75 P/Share
|
|
Apr 08
2024
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
12,500
-11.98%
|
$1,150,000
$92.5 P/Share
|
|
Apr 08
2024
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+19.3%
|
$450,000
$36.75 P/Share
|
|
Apr 08
2024
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
SELL
Open market or private sale
|
Direct |
14,400
-3.83%
|
$1,324,800
$92.49 P/Share
|
|
Apr 08
2024
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
BUY
Exercise of conversion of derivative security
|
Direct |
14,400
+7.11%
|
$518,400
$36.75 P/Share
|
|
Apr 04
2024
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
29,350
-29.79%
|
$2,729,550
$93.04 P/Share
|
|
Apr 04
2024
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
29,350
+46.45%
|
$1,056,600
$36.75 P/Share
|
|
Apr 01
2024
|
Scott B. Ullem CVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,255
-14.19%
|
$689,225
$95.16 P/Share
|
|
Apr 01
2024
|
Scott B. Ullem CVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,255
+21.6%
|
$261,180
$36.75 P/Share
|